Aluminium and beta-2-microglobulin in kidney transplant recipients.
Małyszko
Jolanta
J
Department of Nephology and Internal Medicine, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.
Wołczyński
S
S
Małyszko
J S
JS
Myśliwiec
M
M
D000328:Adult; D000368:Aged; D000535:Aluminum / Q000097:blood*; D001379:Azathioprine / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001842:Bone and Bones / Q000378:metabolism*; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011241:Prednisone / Q000627:therapeutic use; D006435:Renal Dialysis; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000032:analysis*
D015415:Biomarkers; D007166:Immunosuppressive Agents; D010281:Parathyroid Hormone; D001613:beta 2-Microglobulin; D003404:Creatinine; D000535:Aluminum; D001379:Azathioprine; D011241:Prednisone